Gines Diego Miralles - 14 Mar 2025 Form 3 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
Director
Signature
/s/ Peter Slover, Attorney-in-Fact
Issuer symbol
CTNM
Transactions as of
14 Mar 2025
Net transactions value
$0
Form type
3
Filing time
17 Mar 2025, 16:10:19 UTC
Previous filing
18 Jul 2024
Next filing
26 Jun 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTNM Stock Option (right to buy) 14 Mar 2025 Class A Common Stock 5,000 $17.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted under the Issuer's 2024 Equity Incentive Plan. The option is fully vested.

Remarks:

Exhibit 24 - Power of Attorney